Study for Children & Adolescent With Severe Asthma With an Eosinophilic Phenotype Treated With Mepolizumab

NCT05139381 · clinicaltrials.gov ↗

UNKNOWN

Status

148

Enrollment

OTHER

Sponsor class

Conditions

Asthma in Children

Interventions

DRUG: Mepolizumab

Sponsor

King's College Hospital NHS Trust